Oil and Energy

The X-Change Corporation will withhold actual production figures on the N.P. Caddie Fisher well until production has settled down and flow rates are adjusted.

The X-Change Corporation has cut overhead and committed a high percentage of its internal resources to purchase additional leases and increase production on existing wells. The company’s principals have foregone salaries to help increase cash flow and bolster shareholder value.

The firm has budgeted funds to deepen two wells in the lower Woodbine formation by 60 to 80 feet. Operators on adjoining leases have been flowing at 150 BOPD for 60-90 days. The X-Change Corporation and its production subsidiaries expect similar results and a rig is scheduled in mid-February.

The X-Change Corporation will also continue to develop 22 wells identified as having substantial Proven Reserves, discounted at PV 10 of 10 million barrels. These equipped wells are in good condition and prompt resumption of production will create immediate cash flow for the company.

The X-Change Corporation is the exclusive marketer of Micro-TES products in the North America. The Board of Directors is currently developing an aggressive marketing strategy for its Paragone bio-tech procedure to maximize profit. Paragone solubilizes paraffin and asphaltene in formations, well bores, pumps, flow lines, heater treaters and storage tanks. The product reduces or eliminates emulsion, BS&W, corrosion, scale, hydrogen sulfide and oil carry over. Paragone releases drilling fluid, frac gels, polymers and soap from the formation. It increases API gravity, oil production, gas production and water injection rates. Treatments with the product have resulted in significant savings for operators when compared to the cost of chemical treatments.

By illustrating its own successes using the Paragone treatment and pointing to significant increases in oil production in its own wells, The X-Change Corporation stands on solid marketing ground. As word reaches the industry of its success, sales of The X-Change Corporation and Micro-TES’ Bio Tech products and procedure will generate higher net revenues and shareholder value.

# # #

Forward-Looking Statements:
Except for historical information contained herein, the statements made in this release constitute forward-looking statements (including within the meaning of Section 27A of the United States Securities Act of 1933 and Section 21E of the United States Securities Exchange Act of 1934). Such forward-looking statements are based on current expectations that are subject to significant risks and uncertainties that are difficult to predict, including statements regarding the intent, belief, or current expectations of the X-Change Corporation. These forward-looking statements include, among other things, statements regarding future events and the future financial performance of the X-Change Corporation that involve risks and uncertainties. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results. Readers are referred to the documents filed by the X-Change Corporation, which are on file with the U.S. Securities and Exchange Commission and may be accessed at http://www.sec.gov or the X-Change Corporation’s investor relations web page at http://www.xchangecorp.com/index.html, and specifically the most recent reports on Form 10-K and 10-Q, each as it may be amended from time to time, which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The X-Change Corporation disclaims any obligation to update or correct any forward-looking statements made herein due to the occurrence of events after the issuance of this press release.

For further information, please contact Michael P. McInerney at (214) 397-0055.

Source X-Change Corporation